Related references
Note: Only part of the references are listed.Common risk factors for heart failure and cancer
Wouter C. Meijers et al.
CARDIOVASCULAR RESEARCH (2019)
Representation of Patients With Cardiovascular Disease in Pivotal Cancer Clinical Trials
Janice Bonsu et al.
CIRCULATION (2019)
Increased risk of cancer death in patients with chronic heart failurewith a special reference to inflammation-A report from the CHART-2 Study
Takuya Oikawa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Cancer and heart disease: associations and relations
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise
Pedro Moliner et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Health care utilization and mortality associated with heart failure-related admissions among cancer patients
Avirup Guha et al.
ESC HEART FAILURE (2019)
Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86000 Individuals
Nathalie Conrad et al.
JAMA CARDIOLOGY (2019)
A population-based study of cardiovascular diseasemortality risk in US cancer patients
Kathleen M. Sturgeon et al.
EUROPEAN HEART JOURNAL (2019)
Heart Failure Stimulates Tumor Growth by Circulating Factors
Wouter C. Meijers et al.
CIRCULATION (2018)
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge
Pietro Ameri et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study
Annamaria Iorio et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Lack of Association Between Heart Failure and Incident Cancer
Senthil Selvaraj et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Linking Heart Failure to Cancer: Background Evidence and Research Perspectives
Edoardo Bertero et al.
CIRCULATION (2018)
QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study
A. Andrea Pozzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Does the pathophysiology of heart failure prime the incidence of cancer?
Mari Sakamoto et al.
HYPERTENSION RESEARCH (2017)
Mode of Death in Heart Failure With Preserved Ejection Fraction
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Declining Risk of Sudden Death in Heart Failure
Li Shen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Incidence of cancer in patients with chronic heart failure: a long-term follow-up study
Ann Banke et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer
Tal Hasin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S. Desai et al.
EUROPEAN HEART JOURNAL (2015)
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials
Christopher J. Rush et al.
JACC-HEART FAILURE (2015)
Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study
Marie Louise A. Luttik et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
Gerhard Hindricks et al.
LANCET (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Patients With Heart Failure Have an Increased Risk of Incident Cancer
Tal Hasin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
Frank Ruschitzka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The STICH Trial (Surgical Treatment for Ischemic Heart Failure)
Peter Carson et al.
JACC-HEART FAILURE (2013)
Effect of Amlodipine on the Survival of Patients With Severe Chronic Heart Failure Due to a Nonischemic Cardiomyopathy Results of the PRAISE-2 Study (Prospective Randomized Amlodipine Survival Evaluation 2)
Milton Packer et al.
JACC-HEART FAILURE (2013)
Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure The Telemedical Interventional Monitoring in Heart Failure Study
Friedrich Koehler et al.
CIRCULATION (2011)
Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure
Christopher M. O'Connor et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure.
Anthony S. L. Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure)
Andrea Mortara et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial
Christopher M. O'Connor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Marvin A. Konstam et al.
LANCET (2009)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events.
Arthur J. Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Safety and Efficacy of Outpatient Nesiritide in Patients With Advanced Heart Failure Results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) Trial
Clyde W. Yancy et al.
CIRCULATION-HEART FAILURE (2008)
Design of the Heart failure Endpoint evaluation of AII-Antagonist Losartan (HEAAL) study in patients intolerant to ACE-inhibitor
Marvin A. Konstam et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study
Arash Arya et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Impact of oxypurinol in patients with symptomatic heart failure
Joshua M. Hare et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
Cecilia Linde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Results of a non-specific immunomodulation therapy on chronic heart failure (ACCLAIM trial):: a placebo-controlled randomised trial
Guillermo Torre-Amione et al.
LANCET (2008)
Rhythm control versus rate control for atrial fibrillation and heart failure
Denis Roy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure:: The ACCLAIM trial rationale and design
Guillermo Torre-Amione et al.
CANADIAN JOURNAL OF CARDIOLOGY (2007)
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence - Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III
R Willenheimer et al.
CIRCULATION (2005)
The effect of cardiac resynchronization on morbidity and mortality in heart failure
JGF Cleland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
GH Bardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III
R Willenheimer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III-IV congestive heart failure
RS Freudenberger et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Tolerability of carvedilol and ACE-inhibition in mild heart failure.: Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)
M Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
SD Solomon et al.
CIRCULATION (2004)
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
MR Bristow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
A Kadish et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias
SL Higgins et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)
JN Cohn et al.
EUROPEAN JOURNAL OF HEART FAILURE (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
CB Granger et al.
LANCET (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
PA Poole-Wilson et al.
LANCET (2003)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points
JGF Cleland et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
The Carvedilol and ACE-inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN) - Rationale and design
WJ Remme
CARDIOVASCULAR DRUGS AND THERAPY (2001)
Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial
MR Bristow et al.
JOURNAL OF CARDIAC FAILURE (2000)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
B Pitt et al.
LANCET (2000)
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure - The MACH-1 study
TB Levine et al.
CIRCULATION (2000)
Share Paper
